Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT00019097Phase 2Completed
Vaccine Therapy in Treating Patients With Multiple Myeloma
Refractory Plasma Cell NeoplasmStage II Multiple MyelomaStage III Multiple Myeloma
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Cancer Institute (NCI)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mohamad A. Hussein, MD

The Cleveland Clinic

Moderately Similar
8 trials

Shared therapeutic areas:

Refractory Plasma Cell NeoplasmStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

James R. Berenson, MD

Oncotherapeutics

Moderately Similar
5 trials

Shared therapeutic areas:

Refractory Plasma Cell NeoplasmStage II Multiple MyelomaStage III Multiple Myeloma
Similarity Score30%

Erica Campagnaro

Case Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Ann Mohrbacher, MD

University of Southern California

Related
4 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Craig Hofmeister, MD

Ohio State University

Related
4 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma
Similarity Score20%

Robert Kyle

Eastern Cooperative Oncology Group

Related
1 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Zaid Al-Kadhimi

Barbara Ann Karmanos Cancer Institute

Related
1 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Alexander Stewart

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Angela Dispenzieri

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Stage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00019097Phase 2StudyChair

Vaccine Therapy in Treating Patients With Multiple Myeloma

Refractory Plasma Cell NeoplasmStage II Multiple MyelomaStage III Multiple Myeloma
Completed

All 1 trials loaded